good morning america semaglutide Active ingredient in Ozempic, Wegovy

Research participants on semaglutide at maintenance doses showed an average of 15 to 17% body weight reduction over 68 weeks in the landmark clinical trials

Semaglutide has already become more than just a vanity drug. Clinical trials like SUSTAIN-6 and FLOW have shown it can slash the risk of kidney disease, reduce major heart attacks, and even lower all-cause mortality in high-risk groups

Switching products on account of hair loss alone is therefore rarely the answer, especially as some of the alternatives carry a higher risk

This natural alternation gives each side a minimum of two weeks rest between injections within the same general area

Supporting Performance While Your Body Changes